Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

110 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Atrial Fibrillation Burden and Atrial Shunt Therapy in Heart Failure With Preserved Ejection Fraction.
Patel RB, Reddy VY, Komtebedde J, Wegerich SW, Sekaric J, Swarup V, Walton A, Laurent G, Chetcuti S, Rademann M, Bergmann M, McKenzie S, Bugger H, Bruno RR, Herrmann HC, Nair A, Gupta DK, Lim S, Kapadia S, Gordon R, Vanderheyden M, Noel T, Bailey S, Gertz ZM, Trochu JN, Cutlip DE, Leon MB, Solomon SD, van Veldhuisen DJ, Auricchio A, Shah SJ. Patel RB, et al. Among authors: chetcuti s. JACC Heart Fail. 2023 Oct;11(10):1351-1362. doi: 10.1016/j.jchf.2023.05.024. Epub 2023 Jul 19. JACC Heart Fail. 2023. PMID: 37480877 Clinical Trial.
Missed opportunities to treat atherosclerosis in patients undergoing peripheral vascular interventions: insights from the University of Michigan Peripheral Vascular Disease Quality Improvement Initiative (PVD-QI2).
Mukherjee D, Lingam P, Chetcuti S, Grossman PM, Moscucci M, Luciano AE, Eagle KA. Mukherjee D, et al. Among authors: chetcuti s. Circulation. 2002 Oct 8;106(15):1909-12. doi: 10.1161/01.cir.0000035649.39669.ce. Circulation. 2002. PMID: 12370211 Clinical Trial.
Impact of extracardiac vascular disease on acute prognosis in patients who undergo percutaneous coronary interventions (data from the Blue Cross & Blue Shield of Michigan Cardiovascular Consortium [BMC2]).
Mukherjee D, Eagle KA, Smith DE, Kline-Rogers EM, Chetcuti S, Grossman PM, Nallamothu B, O'Donnell M, DeFranco A, Maxwell-Eward A, McGinnity J, Meengs WM, Patel K, Moscucci M; Blue Cross & Blue Shield of Michigan Cardiovascular Consortium (BMC2). Mukherjee D, et al. Among authors: chetcuti s. Am J Cardiol. 2003 Oct 15;92(8):972-4. doi: 10.1016/s0002-9149(03)00981-0. Am J Cardiol. 2003. PMID: 14556876
A comparison of abciximab and small-molecule glycoprotein IIb/IIIa inhibitors in patients undergoing primary percutaneous coronary intervention: a meta-analysis of contemporary randomized controlled trials.
Gurm HS, Tamhane U, Meier P, Grossman PM, Chetcuti S, Bates ER. Gurm HS, et al. Among authors: chetcuti s. Circ Cardiovasc Interv. 2009 Jun;2(3):230-6. doi: 10.1161/CIRCINTERVENTIONS.108.847996. Epub 2009 Apr 21. Circ Cardiovasc Interv. 2009. PMID: 20031720
110 results